These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 26733005)

  • 1. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.
    Shum M; Bellmann K; St-Pierre P; Marette A
    Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
    Veilleux A; Houde VP; Bellmann K; Marette A
    Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mitochondrial complex 1 by the S6K1 inhibitor PF-4708671 partly contributes to its glucose metabolic effects in muscle and liver cells.
    Shum M; Houde VP; Bellemare V; Junges Moreira R; Bellmann K; St-Pierre P; Viollet B; Foretz M; Marette A
    J Biol Chem; 2019 Aug; 294(32):12250-12260. PubMed ID: 31243102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
    Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
    Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.
    Copps KD; Hançer NJ; Qiu W; White MF
    J Biol Chem; 2016 Apr; 291(16):8602-17. PubMed ID: 26846849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium.
    Leontieva OV; Demidenko ZN; Blagosklonny MV
    Cell Death Dis; 2014 May; 5(5):e1214. PubMed ID: 24810050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute rapamycin treatment improved glucose tolerance through inhibition of hepatic gluconeogenesis in rainbow trout (Oncorhynchus mykiss).
    Dai W; Panserat S; Terrier F; Seiliez I; Skiba-Cassy S
    Am J Physiol Regul Integr Comp Physiol; 2014 Nov; 307(10):R1231-8. PubMed ID: 25163922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
    Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
    Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice.
    Bermudez-Silva FJ; Romero-Zerbo SY; Haissaguerre M; Ruz-Maldonado I; Lhamyani S; El Bekay R; Tabarin A; Marsicano G; Cota D
    Dis Model Mech; 2016 Jan; 9(1):51-61. PubMed ID: 26563389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.
    Houde VP; Brûlé S; Festuccia WT; Blanchard PG; Bellmann K; Deshaies Y; Marette A
    Diabetes; 2010 Jun; 59(6):1338-48. PubMed ID: 20299475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
    Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
    BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronarin A modulated hepatic glycogen synthesis and gluconeogenesis via inhibiting mTORC1/S6K1 signaling and ameliorated glucose homeostasis of diabetic mice.
    Huang SL; Xie W; Ye YL; Liu J; Qu H; Shen Y; Xu TF; Zhao ZH; Shi Y; Shen JH; Leng Y
    Acta Pharmacol Sin; 2023 Mar; 44(3):596-609. PubMed ID: 36085523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.
    Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS
    PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin-induced food intake and adiposity depend on central mTORC1/S6K1 signaling.
    Stevanovic D; Trajkovic V; Müller-Lühlhoff S; Brandt E; Abplanalp W; Bumke-Vogt C; Liehl B; Wiedmer P; Janjetovic K; Starcevic V; Pfeiffer AF; Al-Hasani H; Tschöp MH; Castañeda TR
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):280-90. PubMed ID: 23994018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved insulin sensitivity by rapamycin is associated with reduction of mTOR and S6K1 activities in L6 myotubes.
    Hwang SL; Li X; Lee JY; Chang HW
    Biochem Biophys Res Commun; 2012 Feb; 418(2):402-7. PubMed ID: 22281494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
    Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
    J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation.
    Zhu Y; Pereira RO; O'Neill BT; Riehle C; Ilkun O; Wende AR; Rawlings TA; Zhang YC; Zhang Q; Klip A; Shiojima I; Walsh K; Abel ED
    Mol Endocrinol; 2013 Jan; 27(1):172-84. PubMed ID: 23204326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.